OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 11/01/2024
Week ended 11/01/2024
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 11/01/2024
- The Week’s Most Important Closed M&A Transactions:
- On October 28, 2024, Decibel Cannabis (D.B.: TSX) closed its acquisition of Agmedica Bioscience, a subsidiary of Atlas Global Brands, which is operating under Canadian bankruptcy (CCAA) proceedings.
- The company was acquired from Callisto pursuant to an assignment agreement via a seller note for $4.54M.
- Agmedica is expected to materially expand Decibel’s international footprint with EU GMP certification that enables the export of flower and extract products, with sales in 7 countries, including Australia, Denmark, Germany, Israel, Norway, Spain, and the U.K.
- Decibel estimates that Agmedical could add $30M of net revenue and $4M of EBITDA in 2025, pegging the EV/NTM EBITDA at 1.6x.
Week ended 11/01/2024
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.